HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.
Poloznikov AA, Nersisyan SA, Hushpulian DM, Kazakov EH, Tonevitsky AG, Kazakov SV, Vechorko VI, Nikulin SV, Makarova JA, Gazaryan IG.
Poloznikov AA, et al.
Front Pharmacol. 2021 Jan 29;11:621054. doi: 10.3389/fphar.2020.621054. eCollection 2020.
Front Pharmacol. 2021.
PMID: 33584306
Free PMC article.
Review.